SPC126
S-{2-[1-(3-etoxý-4-metoxýfenýl)-2-metýlsúlfónýletýl]-4-asetýlamínóísóindólín-1,3-díón}
Status:
AfskrifuðApplication date:
15.7.2015Application published:
15.9.2015
Medicine name:
Otezla - apremilastMedicine for children:
No
Timeline
Today
15.7.2015Application
15.9.2015Publication
Marketing license
IS authorization number:
EU/1/14/981/001-003
Foreign authorization number:
EU/1/14/981
Owner
Name:
Amgen (Europe) GmbHAddress:
Floor 6-8, Suurstoffi 22, Risch – Rotkreuz CH
Agent
Name:
Ólafur Ragnarsson hrl., PaticeAddress:
Pósthólf 8236, 128 Reykjavík
Patent
Number:
EP2276483